IMM 4.92% 32.0¢ immutep limited

running the trial. But $100 mil won’t cover it and all the other...

  1. 1,607 Posts.
    lightbulb Created with Sketch. 380
    correct. What’s the profit on $100mil supply of Keytruda?
    Essentially Merck is paying peanuts. This is a zero risk equation for them and all the risk is on shareholders.

    There’s no risk reduction for shareholders in this deal.
    running the trial. But $100 mil won’t cover it and all the other things they are doing. They will have to come back to the market again in 12 months.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.015(4.92%)
Mkt cap ! $464.8M
Open High Low Value Volume
30.0¢ 32.5¢ 30.0¢ $1.168M 3.702M

Buyers (Bids)

No. Vol. Price($)
5 148547 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 51809 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.